Literature DB >> 1388194

Tumor necrosis factor-alpha and IFN-gamma expression in human thymus. Localization and overexpression in Down syndrome (trisomy 21).

M Murphy1, D S Friend, L Pike-Nobile, L B Epstein.   

Abstract

In vitro studies suggest that TNF-alpha and IFN-gamma regulate thymocyte proliferation, but little evidence exists for the constitutive production of these cytokines in normal human thymus. In paired experiments, we examined frozen sections of postnatal human thymus from four control children and four age-matched children with Down syndrome (DS) (trisomy 21) for TNF-alpha and IFN-gamma mRNA expression using in situ hybridization. We studied thymuses from children with DS because this aneuploid condition is associated with a greatly increased incidence of infection and has abnormal thymic anatomy and patterns of thymocyte maturation. We found cells expressing constitutive levels of TNF-alpha mRNA in the trabeculae, corticomedullary junctions, and medulla of both control and DS thymuses and the number of these cells was an average of 3.9-fold higher in DS thymuses than in age-matched control thymuses. DS thymuses also contained an average of 3 fold higher numbers of cells with mast cell morphology, identified by toluidine blue histologic staining and electron microscopy. In both DS and control thymuses the mast cells colocalized with TNF-alpha mRNA-expressing cells. In addition, TNF-alpha protein- expressing cells, identified by immunohistochemistry, displayed a granular pattern of staining that is characteristic of mast cells. These results suggest that mast cells may be one source of TNF-alpha in human postnatal thymus. Discrete cells expressing IFN-gamma mRNA were distinctly localized to the cortical region of both DS and control thymuses and were 2.4-fold more abundant in DS thymuses than in the controls. Our results demonstrate, for the first time, the constitutive production and location of TNF-alpha and IFN-gamma in postnatal human thymus. The overexpression of both of these cytokines in DS thymuses suggests a dysregulation in cytokine production in DS and may provide an explanation for the abnormal thymic anatomy and thymocyte maturation associated with this syndrome.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1388194

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

1.  Mast cell lineage diversion of T lineage precursors by the essential T cell transcription factor GATA-3.

Authors:  Tom Taghon; Mary A Yui; Ellen V Rothenberg
Journal:  Nat Immunol       Date:  2007-07-01       Impact factor: 25.606

2.  T-helper-related cytokines in gingival crevicular fluid from adolescents with Down syndrome.

Authors:  Georgios Tsilingaridis; Tülay Yucel-Lindberg; Thomas Modéer
Journal:  Clin Oral Investig       Date:  2011-01-08       Impact factor: 3.573

3.  Defective thymic progenitor development and mature T-cell responses in a mouse model for Down syndrome.

Authors:  Laureanne P E Lorenzo; Kristen E Shatynski; Sarah Clark; Paul J Yarowsky; Mark S Williams
Journal:  Immunology       Date:  2013-08       Impact factor: 7.397

4.  Serum levels of gamma interferon in patients with Down's syndrome.

Authors:  D Torre; M Broggini; C Zeroli; L Agrifoglio; V Bottà; R Casalone; G Ferrario
Journal:  Infection       Date:  1995 Jan-Feb       Impact factor: 3.553

5.  Reduced neuronal co-localisation of nardilysin and the putative alpha-secretases ADAM10 and ADAM17 in Alzheimer's disease and Down syndrome brains.

Authors:  Hans-Gert Bernstein; Rolf Stricker; Uwe Lendeckel; Iris Bertram; Henrik Dobrowolny; Johann Steiner; Bernhard Bogerts; Georg Reiser
Journal:  Age (Dordr)       Date:  2008-08-30

Review 6.  Superantigens and pseudosuperantigens of gram-positive cocci.

Authors:  B Fleischer; D Gerlach; A Fuhrmann; K H Schmidt
Journal:  Med Microbiol Immunol       Date:  1995-05       Impact factor: 3.402

7.  Down syndrome, autoimmunity and T regulatory cells.

Authors:  F P Pellegrini; M Marinoni; V Frangione; A Tedeschi; V Gandini; F Ciglia; L Mortara; R S Accolla; L Nespoli
Journal:  Clin Exp Immunol       Date:  2012-09       Impact factor: 4.330

Review 8.  Intrinsic defect of the immune system in children with Down syndrome: a review.

Authors:  M A A Kusters; R H J Verstegen; E F A Gemen; E de Vries
Journal:  Clin Exp Immunol       Date:  2009-01-22       Impact factor: 4.330

9.  Mast cells, cytokines, and metalloproteinases at the rheumatoid lesion: dual immunolocalisation studies.

Authors:  L C Tetlow; D E Woolley
Journal:  Ann Rheum Dis       Date:  1995-11       Impact factor: 19.103

10.  Maturation-dependent licensing of naive T cells for rapid TNF production.

Authors:  Bhavana Priyadharshini; Raymond M Welsh; Dale L Greiner; Rachel M Gerstein; Michael A Brehm
Journal:  PLoS One       Date:  2010-11-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.